Article Details

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal - Reuters

Retrieved on: 2023-12-12 20:07:46

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal - Reuters. View article details on hiswai:

Excerpt

AstraZeneca made its first foray into vaccines by co-developing the COVID-19 shot with Oxford University. It set up a separate vaccine and antibody ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo